Key facts
- seqWell’s last known valuation is $36.0M (Feb 2025).
- It has raised $24.5M across 6 recorded rounds; the latest was Seed Round ($3.1M) in Sep 2024.
- Notable investors include BroadOak Capital Partners, Codexis, Current Yield with Participation Fund, InnoVentures Lab, Research Corporation Technologies.
- seqWell has filed 8 Form Ds with the SEC since 2016, most recently Feb 2025 ($3.1M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for seqWell
Funding rounds
6 roundsAbout seqWell
Developer of a next-generation sequencing library prep technology designed to improve the potential of DNA sequencing instruments. The company offers tagmentation-based workflows with built-in normalization, scalable multiplexing capabilities, and compatibility with a range of sequencing applications and instruments, enabling research laboratories, genomic core facilities, and life science scientists to prepare large numbers of sequencing libraries efficiently and consistently to advance biological and medical discoveries.
- Sector
- Healthcare
- HQ
- Beverly, MA, United States
- Founded
- 2014
- Employees
- 39
- Website
- seqwell.com/
- Ownership
- Privately Held (backing)
seqWell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in seqWell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on seqWell in its N-PORT filings yet. We sweep new filings monthly.